Cannabis Law Report

JUNE 1, 2022

This acquisition will accelerate Khiron’s growth in Europe by controlling the complete value chain for its products and gaining direct access to German pharmacies. Pharmadrug GmbH has been active worldwide for almost 40 years as a manufacturer and wholesaler of medicinal products and active pharmaceutical ingredients.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

Veriheal

JUNE 22, 2021

” The doorways opening to new cannabinoid research are monumental. Over the next decade, the United States could stand to see an explosion in the research of cannabinoid therapies. Go figure the federal government chose Mississippi to be the only state where researchers can access medical cannabis legally.

DEA 59

DEA Access Therapy Cannabinoids 59

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. What about other medical cannabis products? ” Source BBC: [link]. PDF Version.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

MMJ Recs

MAY 23, 2024

Medical Marijuana for Chronic Illness Management The traditional approach to managing chronic illnesses often involves a combination of pharmaceutical medications and lifestyle modifications. With its diverse array of cannabinoids, such as THC and CBD, medical marijuana offers a multifaceted approach to addressing chronic symptoms.

Conditions 105

Conditions Chronic Pain Therapy Marijuana 105

Veriheal

SEPTEMBER 27, 2021

The United Kingdom’s Multiple Sclerosis (MS) Society has taken a stand against restricted access to medical cannabis in the country. The society launched a campaign with the hashtag #ApprovedButDenied protesting the difficulty so many patients have faced attempting to obtain medical cannabis. ApprovedButDenied.

Treatment 98

Treatment Patients Access Research and Development 98

United Patients Group

MAY 17, 2023

Some researchers believe that cannabinoids may help people with ASD manage anxiety and stress by increasing their ability to focus and pay attention. Cannabinoids have been shown to help people with autism manage anxiety and stress.

Sleep 81

Sleep Cannabinoids Patients CBD 81

The Cannigma

JUNE 2, 2022

Ever wondered how cannabinoids like THC or CBD affect your blood? It turns out that this issue has been under-researched and could have significant impacts on patients who may be at greater risk of heart attacks and strokes. The short answer is – no, in most cases cannabinoids do not seem to act as strong blood thinners.

Blood Pressure 112

Blood Pressure Cannabinoids Patients THC 112

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Work with U.S.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

PrestoDoctor

SEPTEMBER 6, 2023

It has been a go-to option for healthcare professionals seeking to manage pain effectively for their patients. The plant’s active compounds, cannabinoids, interact with the body’s endocannabinoid system, which plays a crucial role in regulating pain perception.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

SpeedWeed

MARCH 13, 2021

Almost 25% of patients with Parkinson’s disease reported that they had used cannabis in the prior six months in a survey from the Parkinson’s Foundation. Parkinson’s disease patients typically use pharmaceutical medications to treat their condition with varying degrees of success. More Than 1,000 PD Patients Surveyed.

Patients 52

Patients Treatment Therapy Sleep 52

MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. Whether used alone or in combination with other cannabinoids, CBD has shown promise in addressing a wide range of health concerns.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

OCTOBER 26, 2021

Following this selection, Tilray will supply a variety of its pharmaceutical-grade medical cannabis products, including extracts and dried flower with different degrees of THC and CBD for patients with varying medical conditions.

Pharmaceutical 52

Pharmaceutical Research and Development Patients Access 52

Cannabis Law Report

FEBRUARY 18, 2022

We are one of the first to successfully complete a commercial shipment of Colombian-manufactured high-CBD pharmaceutical product to Germany available for patients in pharmacies under prescription. Ethypharm aspires to work closely with doctors and pharmacists to improve patients’ lives.

Extraction 52

Extraction Pharmaceutical Patients Cannabinoids 52

Cannabis Law Report

DECEMBER 22, 2021

With growing interest in sustainable and bio-based cannabinoids, and after completing a strategic review of Hyasynth including their intellectual property (IP) and R&D platforms, Organigram remains excited about Hyasynth’s future and growth plans. million of secured convertible debentures in Hyasynth (the “Debentures”).

Cannabinoids 52

Cannabinoids Research and Development Events Pharmaceutical 52

MMJ Recs

JANUARY 17, 2024

As the legal landscape surrounding cannabis continues to evolve, an increasing number of arthritis patients are turning to this plant for potential relief. How Medical Marijuana Can Help Arthritis Patients Medical marijuana holds significant promise in providing relief and improving the quality of life for arthritis patients.

Strains 98

Strains Marijuana Indica Microdosing 98

Veriheal

OCTOBER 13, 2020

Elevated levels of stress can even land these individuals in more discomfort, with IBD patients risking hospitalization due to inflammation. Factors such as diet and stress are known to aggravate IBD patients, but they do not cause it. . What is IBS? What is the Difference Between IBD and IBS?

Digestion 123

Digestion Treatment Conditions Research and Development 123

MJ Business Attorneys

JUNE 29, 2018

Epidiolex is the first drug the FDA has approved that contains a substance derived from marijuana, and it is also the first drug approved by the FDA to be used to treat patients with Dravet syndrome.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Cannabis Law Report

SEPTEMBER 14, 2022

The cannabis-based treatment, Sativex, will now be available via NHS prescription in Scotland, to treat spasticity in MS patients. Although a limited number of people have been able to access it via the Peer Approved Clinical System (PACS) Tier 2 individual patient treatment request process.

Treatment 52

Treatment Access Patients Medicine 52

Cannabis Law Report

FEBRUARY 27, 2022

The research and development company simultaneously retains its listing of shares on the Australian Stock Exchange, but notes that the dual listing means it is more accessible to a wider audience of investors “with sophisticated understandings of medicinal cannabinoids, psychedelic therapies, and pharmaceutical development”.

Medicine 52

Medicine Research and Development Therapy Pharmaceutical 52

Cannabis Law Report

JULY 5, 2021

The company notes 65% of prescriptions filled during FY2021 were for repeat patients. Bod also has a prescription product available to Australians – a pharmaceutical grade cannabidiol (CBD) based formulation called Medicabilis. Some of these other than CBD, THC and CBG may also have therapeutic benefits.

Cannabinoids 95

Cannabinoids CBD Pharmaceutical Access 95

Veriheal

MAY 17, 2021

Many of them even offer the ability for visiting medical cannabis patients from other states to participate in their programs. Other states have gone beyond just medical access and have also legalized retail cannabis markets for adult consumers. That is perhaps the biggest lie that is being perpetuated on the Alabama public today.

Legalization 86

Legalization Pharmaceutical Therapy Chronic Pain 86

Veriheal

DECEMBER 10, 2021

The Louisiana Department of Health recently notified businesses about an opportunity to obtain a license for making foods that contain cannabinoids. Consumable hemp is defined as “any product derived from industrial hemp that contains any cannabinoids and is intended for consumption or topical use.”

THC 97

THC Cannabinoids Hemp Chronic Pain 97

The Cannigma

JUNE 14, 2021

All that is about to change, thanks to a change at the DEA , which cultivators and industry experts say will be monumental for cannabis research, medical marijuana patients, and potentially the broader legal status of the plant itself. “We So what will it mean that researchers may soon have dozens of producers and growers to choose from? “We

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

MMJ Recs

FEBRUARY 18, 2024

This comprehensive article aims to explore the myriad health benefits of medical marijuana, delving into its therapeutic potential, impact on mental health, role in managing chronic conditions, and the holistic healing it offers, with a special focus on cannabinoids like CBD.

Chronic Pain 52

Chronic Pain Marijuana Epilepsy Research and Development 52

The Cannigma

JUNE 1, 2021

Under the plan, some 3,000 patients in France will be treated with medical cannabis and monitored closely. Patients can take part if they have a medical condition which has not responded to pharmaceutical drugs. Patients can take part if they have a medical condition which has not responded to pharmaceutical drugs.

Law 113

Law Epilepsy Programs Patients 113

PrestoDoctor

OCTOBER 13, 2023

Whether you are a medical professional, a patient, or simply someone curious about the world of medical marijuana, this post will provide you with the information you need to make informed decisions about your health. However, unlike marijuana, Marinol is a FDA-approved pharmaceutical drug. 5, or 10 milligrams of THC.

THC 98

THC Chronic Pain Treatment Conditions 98

Puff Puff Post

JUNE 5, 2019

As time started to pass by, the healing theories of marijuana plants were quickly replaced by those of big pharmaceutical companies. It wasn’t until the movement by thousands of patients and patient advocates in the 1990’s that propelled the government to allow fair access to medical marijuana.

Medicine 96

Medicine Patients Cannabinoids Oil 96

Canna Care Docs

SEPTEMBER 18, 2020

Patients under the age of 18 must also have a parent or guardian registered as a caregiver on their behalf. Patients may purchase a 90 day supply of their medication. Patients may purchase medical cannabis in oil-based preparations such as lozenges, capsules, and vape pens. Can a Qualifying Patient Grow Cannabis in Virginia?

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Veriheal

AUGUST 2, 2023

When trying to raise little humans into respectful, productive members of society that will one day raise a family and hopefully do the same, it is sometimes very hard to remain patient. Unfortunately, every pharmaceutical medication on the market comes with a number of side effects — some of which are quite extensive, and severe.

Microdosing 98

Microdosing Consumption Pharmaceutical Cannabis 98

The Cannigma

FEBRUARY 4, 2021

When it comes to cannabis and the struggle for legalization, improving access, and changing hearts and minds, advocates often find themselves up against decades-old myths, misconceptions, and stereotypes that have been delivered from authoritative sources for so long that for many people they supplant the truth. No-go, say the Feds.

THC 145

THC Cannabinoids Blood Pressure Conditions 145

Cannabis Law Report

APRIL 28, 2022

High-quality cannabis flowers from DEMECAN’s German high-end facility are now available to patients. DEMECAN is the only independent German cannabis producer supplying patients in Germany with cannabis flowers from its own EU-DEMECAN has established itself as the only independent producer of medical cannabis and leading wholesaler in Germany.

Pharmaceutical 52

Pharmaceutical Cultivation Collective Patients 52

Leaf Science

JULY 23, 2019

In spite of this, research has shown that THC as much as the other cannabinoids present in cannabis has medicinal value to humans. In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex.

Strains 74

Strains Cannabinoids Epilepsy THC 74

Sensi Seeds

JANUARY 4, 2019

Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). Patients should first meet with a health-care practitioner to determine if cannabis can be beneficial in treating their symptoms. Context of the Medicinal Cannabis Situation.

Medicine 75

Medicine Research and Development Patients Programs 75

MMJ Recs

JANUARY 22, 2024

Among these, medical marijuana edibles have emerged as a discreet and palatable option for patients seeking the therapeutic benefits of cannabis without the traditional methods of smoking or vaporizing. This delayed onset is due to the digestive process, as cannabinoids are metabolized in the liver before entering the bloodstream.

Edibles 52

Edibles Marijuana Chronic Pain THC 52

Veriheal

JANUARY 15, 2021

So does that mean that there is no access to THC for patients in the country? The Medical Cannabis Access Programme. This legislation outlines the requirements for certain patients to have access to the MCAP. This legislation outlines the requirements for certain patients to have access to the MCAP.

Legalization 57

Legalization Therapy Access Legislation 57

Cannabis Law Report

SEPTEMBER 20, 2021

provides Heritage and subsidiary Opticann the benefits of offering patients access to safe, convenient, and effective CB4 products developed on trusted technology platforms. The products leverage pharmaceutical technology to maximize performance and safety. TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp.

Clinical Trials 52

Clinical Trials Pharmaceutical Data Patients 52

Cannabis Law Report

NOVEMBER 30, 2021

LONDON–(BUSINESS WIRE)– #cannabinoids –Óskare Capital is proud to announce the launch of the first ever SEIS and EIS fund targeting the Medical and Pharmaceutical Cannabis sector. The Fund aims to provide UK retail investors with access to a diversified portfolio of companies in this rapidly growing sector.

Pharmaceutical 52

Pharmaceutical Cannabinoids Epilepsy Sleep 52